Author:
Belmatoug Nadia,Heraoui Djazia
Reference41 articles.
1. Gaucher Disease;Beutler,2001
2. Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease;Hughes;Br J Haematol,2007
3. Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease;Barton;N Engl J Med,1991
4. Food and Drug Administration (FDA) (2003): Zavesca prescribing data. http://www.fda.gov/cder/foi/label/2003/21348_zavesca_lbl.pdf (last accessed 03 11 08).
5. European Agency for the Evaluation of Medicinal Products (EMEA). (2002). Zavesca prescribing data. http://www.emea.europa.eu/humandocs/PDFs/EPAR/zavesca/H-435-PI-en.pdf (last accessed 07 09 07).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Grossesse et maladie de Gaucher;Journal de Gynécologie Obstétrique et Biologie de la Reproduction;2014-05